Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

[A new case of pityriasis rubra pilaris-like eruption associated with ponatinib, a tyrosine kinase inhibitor].

Krygier J, Leemans G, Forsyth R, de Becker A, Gutermuth J, Grosber M.

Ann Dermatol Venereol. 2018 Jun 11. pii: S0151-9638(18)30442-3. doi: 10.1016/j.annder.2018.04.009. [Epub ahead of print] French.

PMID:
29903676
2.

A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis.

Laureys G, Willekens B, Vanopdenbosch L, Deryck O, Selleslag D, D'Haeseleer M, De Becker A, Dubois B, Dierickx D, Perrotta G, De Wilde V, van Pesch V, Straetmans N, Dive D, Beguin Y, Van Wijmeersch B, Theunissen K, Kerre T, Van de Velde A.

Acta Neurol Belg. 2018 Jun;118(2):161-168. doi: 10.1007/s13760-018-0905-0. Epub 2018 Mar 13.

PMID:
29536270
3.

Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?

Xu S, De Veirman K, De Becker A, Vanderkerken K, Van Riet I.

Leukemia. 2018 Jul;32(7):1500-1514. doi: 10.1038/s41375-018-0061-9. Epub 2018 Feb 22. Review.

4.

Successful Pretreatment Using Plasma Exchange before Thyroidectomy in a Patient with Amiodarone-Induced Thyrotoxicosis.

Tonnelier A, de Filette J, De Becker A, Deweer S, Velkeniers B.

Eur Thyroid J. 2017 Apr;6(2):108-112. doi: 10.1159/000453578. Epub 2017 Feb 18.

5.

False homozygous HLA genotyping results due to copy number neutral loss of heterozygosity in acquired aplastic anaemia.

Heyrman B, De Becker A, Verheyden S, Demanet C.

BMJ Case Rep. 2017 Mar 2;2017. pii: bcr2016217867. doi: 10.1136/bcr-2016-217867.

PMID:
28254831
6.

Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy?

De Becker A, Riet IV.

World J Stem Cells. 2016 Mar 26;8(3):73-87. doi: 10.4252/wjsc.v8.i3.73. Review.

7.

A case report of immunosuppression-related Kaposi's sarcoma after autologous stem cell transplantation.

Heyrman B, De Becker A, Schots R.

BMC Res Notes. 2016 Mar 24;9:188. doi: 10.1186/s13104-016-1991-9.

8.

Mesenchymal Stromal Cell Therapy in Hematology: From Laboratory to Clinic and Back Again.

De Becker A, Van Riet I.

Stem Cells Dev. 2015 Aug 1;24(15):1713-29. doi: 10.1089/scd.2014.0564. Epub 2015 Jun 4. Review.

PMID:
25923433
9.

Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society.

Baron F, Zachée P, Maertens J, Kerre T, Ory A, Seidel L, Graux C, Lewalle P, Van Gelder M, Theunissen K, Willems E, Emonds MP, De Becker A, Beguin Y.

J Hematol Oncol. 2015 Feb 6;8:4. doi: 10.1186/s13045-014-0098-9.

10.

Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.

Vanacker L, Smeets D, Hoorens A, Teugels E, Algaba R, Dehou MF, De Becker A, Lambrechts D, De Greve J.

Anticancer Res. 2014 Oct;34(10):5517-21.

PMID:
25275049
11.

Upregulation of miR-135b is involved in the impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients.

Xu S, Cecilia Santini G, De Veirman K, Vande Broek I, Leleu X, De Becker A, Van Camp B, Vanderkerken K, Van Riet I.

PLoS One. 2013 Nov 6;8(11):e79752. doi: 10.1371/journal.pone.0079752. eCollection 2013.

12.

Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.

Xu S, De Veirman K, Evans H, Santini GC, Vande Broek I, Leleu X, De Becker A, Van Camp B, Croucher P, Vanderkerken K, Van Riet I.

Acta Pharmacol Sin. 2013 May;34(5):699-709. doi: 10.1038/aps.2012.182. Epub 2013 Apr 8.

13.

Carfilzomib: a novel treatment in relapsed and refractory multiple myeloma.

Fostier K, De Becker A, Schots R.

Onco Targets Ther. 2012;5:237-44. doi: 10.2147/OTT.S28911. Epub 2012 Sep 28.

14.

Galactomannan enzymatic immunoassay cross-reactivity caused by Prototheca species.

Van den Bossche D, De Bel A, Hendrickx M, De Becker A, Jacobs R, Naessens A, Piérard D.

J Clin Microbiol. 2012 Oct;50(10):3371-3. doi: 10.1128/JCM.01028-12. Epub 2012 Jul 25.

15.

In vitro expanded bone marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells can acquire CD34 expression and induce sarcoma formation in vivo.

Xu S, De Becker A, De Raeve H, Van Camp B, Vanderkerken K, Van Riet I.

Biochem Biophys Res Commun. 2012 Aug 3;424(3):391-7. doi: 10.1016/j.bbrc.2012.06.118. Epub 2012 Jul 6.

PMID:
22771324
16.

Symptomatic myelodysplasia with normal blood counts: a diagnostic enigma complicating the management of a patient with severe platelet dysfunction.

van der Meeren S, de Becker A, de Waele M, de Smet D, Jochmans K.

Leuk Lymphoma. 2013 Jan;54(1):192-4. doi: 10.3109/10428194.2012.700712. Epub 2012 Jul 9. No abstract available.

PMID:
22680770
17.

Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway.

Xu S, Evans H, Buckle C, De Veirman K, Hu J, Xu D, Menu E, De Becker A, Vande Broek I, Leleu X, Camp BV, Croucher P, Vanderkerken K, Van Riet I.

Leukemia. 2012 Dec;26(12):2546-9. doi: 10.1038/leu.2012.126. Epub 2012 May 8. No abstract available.

PMID:
22652628
18.

Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.

Xu S, Menu E, De Becker A, Van Camp B, Vanderkerken K, Van Riet I.

Stem Cells. 2012 Feb;30(2):266-79. doi: 10.1002/stem.787.

19.

An improved harvest and in vitro expansion protocol for murine bone marrow-derived mesenchymal stem cells.

Xu S, De Becker A, Van Camp B, Vanderkerken K, Van Riet I.

J Biomed Biotechnol. 2010;2010:105940. doi: 10.1155/2010/105940. Epub 2010 Dec 20.

20.

Efficient differentiation of human embryonic stem cells into a homogeneous population of osteoprogenitor-like cells.

Mateizel I, De Becker A, Van de Velde H, De Rycke M, Van Steirteghem A, Cornelissen R, Van der Elst J, Liebaers I, Van Riet I, Sermon K.

Reprod Biomed Online. 2008 May;16(5):741-53.

PMID:
18492382
21.

Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3.

De Becker A, Van Hummelen P, Bakkus M, Vande Broek I, De Wever J, De Waele M, Van Riet I.

Haematologica. 2007 Apr;92(4):440-9.

22.

Evaluation of the effect of backpack load and position during standing and walking using biomechanical, physiological and subjective measures.

Devroey C, Jonkers I, de Becker A, Lenaerts G, Spaepen A.

Ergonomics. 2007 May;50(5):728-42.

PMID:
17454090
23.

Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow.

Snykers S, Vanhaecke T, De Becker A, Papeleu P, Vinken M, Van Riet I, Rogiers V.

BMC Dev Biol. 2007 Apr 2;7:24.

24.

Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms.

Segers VF, Van Riet I, Andries LJ, Lemmens K, Demolder MJ, De Becker AJ, Kockx MM, De Keulenaer GW.

Am J Physiol Heart Circ Physiol. 2006 Apr;290(4):H1370-7. Epub 2005 Oct 21.

25.

Serological survey of Toxoplasma gondii, feline immunodeficiency virus and feline leukaemia virus in urban stray cats in Belgium.

Dorny P, Speybroeck N, Verstraete S, Baeke M, De Becker A, Berkvens D, Vercruysse J.

Vet Rec. 2002 Nov 23;151(21):626-9.

PMID:
12479298

Supplemental Content

Loading ...
Support Center